📰 Aezs News
Page 7 - Aezs News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Aezs. Real-time updates on events, politics, business and more.
April 23, 2023
StockNews.com initiated coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Get Rating) (TSE:AEZ) in a research note published on Thursday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. Separately, HC Wainwright reissued a buy rating and issued a $28.00 price objective on shares of Aeterna Zentaris in a research note on […]
April 8, 2023
StockNews.com assumed coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Get Rating) (TSE:AEZ) in a report published on Tuesday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Separately, HC Wainwright reissued a buy rating and set a $28.00 price target on shares of Aeterna Zentaris in a report on Tuesday, March […]
April 2, 2023
Aeterna Zentaris Inc. (NASDAQ:AEZS – Get Rating) (TSE:AEZ) was the target of a significant decrease in short interest in March. As of March 15th, there was short interest totalling 73,500 shares, a decrease of 15.5% from the February 28th total of 87,000 shares. Based on an average daily trading volume, of 15,100 shares, the days-to-cover […]
April 1, 2023
HC Wainwright reissued their buy rating on shares of Aeterna Zentaris (NASDAQ:AEZS – Get Rating) (TSE:AEZ) in a report issued on Tuesday, Benzinga reports. The brokerage currently has a $28.00 price objective on the biopharmaceutical company’s stock. HC Wainwright also issued estimates for Aeterna Zentaris’ Q1 2023 earnings at ($1.07) EPS, Q2 2023 earnings at […]
March 31, 2023
StockNews.com began coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Get Rating) (TSE:AEZ) in a report published on Monday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. Aeterna Zentaris Price Performance Shares of AEZS stock opened at $2.68 on Monday. The stock has a fifty day moving average price of $3.28 […]
March 29, 2023
HC Wainwright restated their buy rating on shares of Aeterna Zentaris (NASDAQ:AEZS – Get Rating) (TSE:AEZ) in a research report sent to investors on Tuesday, Benzinga reports. HC Wainwright currently has a $28.00 price objective on the biopharmaceutical company’s stock. HC Wainwright also issued estimates for Aeterna Zentaris’ Q1 2024 earnings at ($0.84) EPS, Q2 […]
March 28, 2023
StockNews.com assumed coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Get Rating) (TSE:AEZ) in a research report sent to investors on Monday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. Aeterna Zentaris Trading Down 0.4 % Shares of AEZS opened at $2.63 on Monday. The firm has a market cap of […]
May 21, 2022
StockNews.com initiated coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Get Rating) (TSE:AEZ) in a note issued to investors on Saturday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock. Separately, HC Wainwright lowered their target price on Aeterna Zentaris from $2.00 to $1.50 and set a “buy” rating for the company in […]
May 5, 2022
StockNews.com assumed coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Get Rating) (TSE:AEZ) in a research report issued on Thursday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock. Separately, HC Wainwright cut their price objective on shares of Aeterna Zentaris from $2.00 to $1.50 and set a “buy” rating on the stock […]
April 5, 2022
Aeterna Zentaris (NASDAQ: AEZS) recently received a number of ratings updates from brokerages and research firms: 4/3/2022 – Aeterna Zentaris is now covered by analysts at StockNews.com. They set a “sell” rating on the stock. 3/30/2022 – Aeterna Zentaris had its price target lowered by analysts at HC Wainwright from $2.00 to $1.50. They now […]